This partner call will give clinicians an overview of clinical guidance for the new Pfizer-BioNTech COVID-19 vaccine, which is the first COVID-19 vaccine to be authorized for use in the United States. FDA issued an Emergency Use Authorization for the vaccine on December 11 and the Advisory Committee on Immunization Practices is slated to provide recommendations for use December 12. The session will cover a wide range of topics, including vaccine administration, vaccination of special populations, and contraindications. Participants also will learn how to have meaningful conversations with patients and answer their questions about the new vaccine.

Click link below to join the webinar:
https://www.zoomgov.com/j/1615052786?pwd=bkp2SHZ4bGRWaW1rTDczV3NCV1VBQT09 

Webinar ID: 161 505 2786

Passcode: 818998

Or iPhone one-tap: US: +16692545252,,1615052786#,,,,,,0#,,818998# or +16468287666,,1615052786#,,,,,,0#,,818998#

Or Telephone: Dial (for higher quality, dial a number based on your current location): US: +1 669 254 5252 or +1 646 828 7666

International numbers available: https://www.zoomgov.com/u/al8YymtCO

Advanced registration is not required.